Ikena Oncology Inc. announced a 1-for-12 reverse stock split of its common stock, set to take effect on July 28, 2025. The company will rebrand as "ImageneBio, Inc." with the ticker symbol "IMA." This move will reduce outstanding shares from approximately 48.2 million to around 4 million, while maintaining the authorized share count and par value per share. Fractional shares will be settled with cash payments based on the closing price on July 24, 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ikena Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-163990), on July 24, 2025, and is solely responsible for the information contained therein.